Ground Swell Capital, LLC Abb Vie Inc. Transaction History

Ground Swell Capital, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 11, 2022	SELL	$137.62 - $174.96 $237,256 - $301,631	-1,724 Closed	0 $0
Q1 2022 May 10, 2022	BUY	$131.98 - $163.75 $227,533 - $282,305	1,724 New	1,724 $279,000
Q3 2021 Nov 12, 2021	SELL	$106.4 - $120.78 $203,968 - $231,535	-1,917 Closed	0 $0
Q2 2021 Aug 12, 2021	BUY	$105.21 - $117.21 $201,687 - $224,691	1,917 New	1,917 $216,000

3,694

1.27B

13M

9.79M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $344B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Ground Swell Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Ground Swell Capital, LLC with notifications on news.